Original language | English (US) |
---|---|
Pages (from-to) | 399-400 |
Number of pages | 2 |
Journal | JAMA cardiology |
Volume | 3 |
Issue number | 5 |
DOIs | |
State | Published - May 2018 |
Funding
Dr Harrington reports receiving grants from Astra, Bristol-Myers Squibb, Janssen, Novartis, Portola, the Medicines Company, Sanofi, and CSL Limited; personal fees from Amgen, Bayer, Element Science, Gilead, MyoKardia, and the Medicines Company; and serving on the board of directors of the American Heart Association and Stanford Health Care. No disclosures were reported.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine